Epilepsy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
Fairfield Market Research, a leading provider of market insights, has unveiled a comprehensive report on the Epilepsy Treatment market, the global epilepsy treatment market reaching a significant milestone of US$ 6.9 billion in 2024. The market is projected to continue its upward trajectory, surging to US$ 14.1 billion by the end of 2031.
Understanding Epilepsy and Its Treatment
Epilepsy, a neurological disorder characterized by recurrent seizures, is caused by abnormal electrical activities in the brain. Seizures can manifest in various forms, from convulsions and loss of consciousness to subtle changes in behavior, perception, or sensation. While epilepsy can affect individuals of all ages, it is most frequently diagnosed in children and older adults.
Key Market Insights:
• The treatment segment, comprising drugs and surgery, held a substantial market share of 72.8% in 2022.
• Revenue from epilepsy treatment represented 20.1% of the global neuroscience market in 2022.
Factors Fueling Demand for Epilepsy Treatment
The prevalence of epilepsy has been on the rise worldwide, driven by several factors, including an aging population. Epilepsy is more common among older adults, and as the population ages, the number of individuals with epilepsy is expected to increase. Advances in medical technology have facilitated the diagnosis of epilepsy, while increased awareness of the condition has prompted more individuals to seek medical attention for seizures.
World Health Organization (WHO) Statistics: Until June 2022, epilepsy affected 50 million people worldwide, making it one of the most common neurological conditions. Alarmingly, almost 80% of epileptics reside in low- and middle-income nations, as per WHO.
Furthermore, the incidence of traumatic brain injuries (TBIs) has surged due to various factors, including an increase in road traffic accidents, falls, and sports-related injuries. This escalation in risk factors, such as TBIs, strokes, and brain tumors, underscores the urgency of preventing these conditions and providing appropriate treatment and support to individuals developing epilepsy as a result.
Centers for Disease Control & Prevention (CDC) Findings: People with TBI are 50 times more likely to die due to seizures, according to CDC (2022).
World Stroke Organization Data: The global fact sheet on stroke for 2019 reported 13.7 million new cases of stroke each year globally.
The increasing prevalence of stroke and drug-resistant epilepsy is anticipated to drive demand for advanced epilepsy treatment over the forecasted period.
Country-wise Insights
Landscape in the United States: The U.S. market is experiencing growth primarily due to increased awareness and diagnosis of epilepsy, leading to better identification and treatment of neurological conditions. This progress is a result of education and awareness campaigns, improved diagnostic tools, and enhanced healthcare access.
Epilepsy Treatment in China: In China, the market is burgeoning due to an aging population, rising healthcare costs, and an increasing prevalence of epilepsy. However, gaps in healthcare delivery and social discrimination rooted in cultural beliefs about epilepsy pose challenges to treatment in the country.
Demand in Germany: Germany exhibits a high prevalence of epilepsy, resulting in elevated healthcare costs. Advances in medical technology and heightened awareness of the condition among healthcare professionals have led to higher detection rates, bolstering the epilepsy treatment market.
Competition Landscape
The epilepsy treatment market boasts significant competition, with key players seeking to expand their global presence through partnerships, mergers, acquisitions, and the launch of technologically advanced products.
Key Companies Covered:
• Medtronic PLC
• GlaxoSmithKline PLC
• Sun Pharmaceutical Industries Ltd.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Zydus Cadila Healthcare Ltd.
• Boston Scientific Corporation
• ElectroCore, Inc.
• LivaNova PLC
• Nihon Kohden Corporation
• Natus Medical Incorporated
• Neurosoft, Inc.
• Pfizer, Inc.
• Abbott Laboratories
• Sanofi S.A.
• Cipla Pharmaceuticals
• Torrent Pharmaceuticals Ltd.
Key Segments of Epilepsy Treatment Industry
Diagnosis & Treatment Type:
• Diagnosis
Inpatient
Outpatient
• Treatment Type
Drugs
Lamotrigine
Phenytoin
Carbamazepine
Valproic Acid
Others
Surgery Treatment
Other Treatments
• Devices
Monitoring Devices
Electrocorticography (ECoG) Electrodes
Intraoperative Patient Monitoring Devices
Neurostimulation Devices
Responsive Neurostimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Seizure Type:
• Generalized Seizures
• Focal Seizures
• Both
Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
Service Provider:
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Specialty Clinics
Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.
- 1. Executive Summary
- 1.1. Global Epilepsy Treatment Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2023
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Global Epilepsy Treatment Market Outlook, 2018 – 2031
- 3.1. Global Epilepsy Treatment Market Outlook, by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 3.1.1. Key Highlights
- 3.1.1.1. Diagnosis
- 3.1.1.1.1. Inpatient
- 3.1.1.1.2. Outpatient
- 3.1.1.2. Treatment Type
- 3.1.1.2.1. Drugs
- 3.1.1.2.1.1. Lamotrigine
- 3.1.1.2.1.2. Phenytoin
- 3.1.1.2.1.3. Carbamazepine
- 3.1.1.2.1.4. Valproic Acid
- 3.1.1.2.1.5. Others
- 3.1.1.2.2. Surgery Treatment
- 3.1.1.2.3. Other Treatments
- 3.1.1.3. Devices
- 3.1.1.3.1. Monitoring Devices
- 3.1.1.3.1.1. Electrocorticography (ECoG) Electrodes
- 3.1.1.3.1.2. Intraoperative Patient Monitoring Devices
- 3.1.1.3.2. Neurostimulation Devices
- 3.1.1.3.2.1. Responsive Neurostimulation
- 3.1.1.3.2.2. Deep Brain Stimulation
- 3.1.1.3.2.3. Vagus Nerve Stimulation
- 3.2. Global Epilepsy Treatment Market Outlook, by Seizure Type, Value (US$ Bn), 2018 – 2031
- 3.2.1. Key Highlights
- 3.2.1.1. Generalized Seizures
- 3.2.1.2. Focal Seizures
- 3.2.1.3. Both
- 3.3. Global Epilepsy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 3.3.1. Key Highlights
- 3.3.1.1. Hospital Pharmacies
- 3.3.1.2. Retail Pharmacies
- 3.3.1.3. Drug Stores
- 3.3.1.4. Online Pharmacies
- 3.4. Global Epilepsy Treatment Market Outlook, by Service Provider, Value (US$ Bn), 2018 – 2031
- 3.4.1. Key Highlights
- 3.4.1.1. Hospitals
- 3.4.1.2. Ambulatory Surgical Centers
- 3.4.1.3. Diagnostic Centers
- 3.4.1.4. Specialty Clinics
- 3.5. Global Epilepsy Treatment Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
- 3.5.1. Key Highlights
- 3.5.1.1. North America
- 3.5.1.2. Europe
- 3.5.1.3. Asia Pacific
- 3.5.1.4. Latin America
- 3.5.1.5. Middle East & Africa
- 4. North America Epilepsy Treatment Market Outlook, 2018 – 2031
- 4.1. North America Epilepsy Treatment Market Outlook, by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 4.1.1. Key Highlights
- 4.1.1.1. Diagnosis
- 4.1.1.1.1. Inpatient
- 4.1.1.1.2. Outpatient
- 4.1.1.2. Treatment Type
- 4.1.1.2.1. Drugs
- 4.1.1.2.1.1. Lamotrigine
- 4.1.1.2.1.2. Phenytoin
- 4.1.1.2.1.3. Carbamazepine
- 4.1.1.2.1.4. Valproic Acid
- 4.1.1.2.1.5. Others
- 4.1.1.2.2. Surgery Treatment
- 4.1.1.2.3. Other Treatments
- 4.1.1.3. Devices
- 4.1.1.3.1. Monitoring Devices
- 4.1.1.3.1.1. Electrocorticography (ECoG) Electrodes
- 4.1.1.3.1.2. Intraoperative Patient Monitoring Devices
- 4.1.1.3.2. Neurostimulation Devices
- 4.1.1.3.2.1. Responsive Neurostimulation
- 4.1.1.3.2.2. Deep Brain Stimulation
- 4.1.1.3.2.3. Vagus Nerve Stimulation
- 4.2. North America Epilepsy Treatment Market Outlook, by Seizure Type, Value (US$ Bn), 2018 – 2031
- 4.2.1. Key Highlights
- 4.2.1.1. Generalized Seizures
- 4.2.1.2. Focal Seizures
- 4.2.1.3. Both
- 4.3. North America Epilepsy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 4.3.1. Key Highlights
- 4.3.1.1. Hospital Pharmacies
- 4.3.1.2. Retail Pharmacies
- 4.3.1.3. Drug Stores
- 4.3.1.4. Online Pharmacies
- 4.4. North America Epilepsy Treatment Market Outlook, by Service Provider, Value (US$ Bn), 2018 – 2031
- 4.4.1. Key Highlights
- 4.4.1.1. Hospitals
- 4.4.1.2. Ambulatory Surgical Centers
- 4.4.1.3. Diagnostic Centers
- 4.4.1.4. Specialty Clinics
- 4.5. North America Epilepsy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 4.5.1. Key Highlights
- 4.5.1.1. U.S. Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.2. U.S. Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.3. U.S. Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 4.5.1.4. U.S. Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 4.5.1.5. Canada Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.6. Canada Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.7. Canada Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 4.5.1.8. Canada Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis
- 5. Europe Epilepsy Treatment Market Outlook, 2018 – 2031
- 5.1. Europe Epilepsy Treatment Market Outlook, by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 5.1.1. Key Highlights
- 5.1.1.1. Diagnosis
- 5.1.1.1.1. Inpatient
- 5.1.1.1.2. Outpatient
- 5.1.1.2. Treatment Type
- 5.1.1.2.1. Drugs
- 5.1.1.2.1.1. Lamotrigine
- 5.1.1.2.1.2. Phenytoin
- 5.1.1.2.1.3. Carbamazepine
- 5.1.1.2.1.4. Valproic Acid
- 5.1.1.2.1.5. Others
- 5.1.1.2.2. Surgery Treatment
- 5.1.1.2.3. Other Treatments
- 5.1.1.3. Devices
- 5.1.1.3.1. Monitoring Devices
- 5.1.1.3.1.1. Electrocorticography (ECoG) Electrodes
- 5.1.1.3.1.2. Intraoperative Patient Monitoring Devices
- 5.1.1.3.2. Neurostimulation Devices
- 5.1.1.3.2.1. Responsive Neurostimulation
- 5.1.1.3.2.2. Deep Brain Stimulation
- 5.1.1.3.2.3. Vagus Nerve Stimulation
- 5.2. Europe Epilepsy Treatment Market Outlook, by Seizure Type, Value (US$ Bn), 2018 – 2031
- 5.2.1. Key Highlights
- 5.2.1.1. Generalized Seizures
- 5.2.1.2. Focal Seizures
- 5.2.1.3. Both
- 5.3. Europe Epilepsy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 5.3.1. Key Highlights
- 5.3.1.1. Hospital Pharmacies
- 5.3.1.2. Retail Pharmacies
- 5.3.1.3. Drug Stores
- 5.3.1.4. Online Pharmacies
- 5.4. Europe Epilepsy Treatment Market Outlook, by Service Provider, Value (US$ Bn), 2018 – 2031
- 5.4.1. Key Highlights
- 5.4.1.1. Hospitals
- 5.4.1.2. Ambulatory Surgical Centers
- 5.4.1.3. Diagnostic Centers
- 5.4.1.4. Specialty Clinics
- 5.5. Europe Epilepsy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 5.5.1. Key Highlights
- 5.5.1.1. Germany Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.2. Germany Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.3. Germany Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.4. Germany Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 5.5.1.5. U.K. Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.6. U.K. Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.7. U.K. Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.8. U.K. Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 5.5.1.9. France Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.10. France Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.11. France Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.12. France Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 5.5.1.13. Italy Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.14. Italy Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.15. Italy Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.16. Italy Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 5.5.1.17. Turkey Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.18. Turkey Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.19. Turkey Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.20. Turkey Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 5.5.1.21. Russia Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.22. Russia Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.23. Russia Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.24. Russia Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 5.5.1.25. Rest of Europe Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.26. Rest of Europe Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.27. Rest of Europe Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.28. Rest of Europe Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis
- 6. Asia Pacific Epilepsy Treatment Market Outlook, 2018 – 2031
- 6.1. Asia Pacific Epilepsy Treatment Market Outlook, by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 6.1.1. Key Highlights
- 6.1.1.1. Diagnosis
- 6.1.1.1.1. Inpatient
- 6.1.1.1.2. Outpatient
- 6.1.1.2. Treatment Type
- 6.1.1.2.1. Drugs
- 6.1.1.2.1.1. Lamotrigine
- 6.1.1.2.1.2. Phenytoin
- 6.1.1.2.1.3. Carbamazepine
- 6.1.1.2.1.4. Valproic Acid
- 6.1.1.2.1.5. Others
- 6.1.1.2.2. Surgery Treatment
- 6.1.1.2.3. Other Treatments
- 6.1.1.3. Devices
- 6.1.1.3.1. Monitoring Devices
- 6.1.1.3.1.1. Electrocorticography (ECoG) Electrodes
- 6.1.1.3.1.2. Intraoperative Patient Monitoring Devices
- 6.1.1.3.2. Neurostimulation Devices
- 6.1.1.3.2.1. Responsive Neurostimulation
- 6.1.1.3.2.2. Deep Brain Stimulation
- 6.1.1.3.2.3. Vagus Nerve Stimulation
- 6.2. Asia Pacific Epilepsy Treatment Market Outlook, by Seizure Type, Value (US$ Bn), 2018 – 2031
- 6.2.1. Key Highlights
- 6.2.1.1. Generalized Seizures
- 6.2.1.2. Focal Seizures
- 6.2.1.3. Both
- 6.3. Asia Pacific Epilepsy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 6.3.1. Key Highlights
- 6.3.1.1. Hospital Pharmacies
- 6.3.1.2. Retail Pharmacies
- 6.3.1.3. Drug Stores
- 6.3.1.4. Online Pharmacies
- 6.4. Asia Pacific Epilepsy Treatment Market Outlook, by Service Provider, Value (US$ Bn), 2018 – 2031
- 6.4.1. Key Highlights
- 6.4.1.1. Hospitals
- 6.4.1.2. Ambulatory Surgical Centers
- 6.4.1.3. Diagnostic Centers
- 6.4.1.4. Specialty Clinics
- 6.5. Asia Pacific Epilepsy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 6.5.1. Key Highlights
- 6.5.1.1. China Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.2. China Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.3. China Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.4. China Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 6.5.1.5. Japan Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.6. Japan Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.7. Japan Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.8. Japan Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 6.5.1.9. South Korea Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.10. South Korea Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.11. South Korea Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.12. South Korea Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 6.5.1.13. India Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.14. India Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.15. India Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.16. India Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 6.5.1.17. Southeast Asia Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.18. Southeast Asia Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.19. Southeast Asia Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.20. Southeast Asia Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 6.5.1.21. Rest of Asia Pacific Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.22. Rest of Asia Pacific Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.23. Rest of Asia Pacific Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.24. Rest of Asia Pacific Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis
- 7. Latin America Epilepsy Treatment Market Outlook, 2018 – 2031
- 7.1. Latin America Epilepsy Treatment Market Outlook, by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 7.1.1. Key Highlights
- 7.1.1.1. Diagnosis
- 7.1.1.1.1. Inpatient
- 7.1.1.1.2. Outpatient
- 7.1.1.2. Treatment Type
- 7.1.1.2.1. Drugs
- 7.1.1.2.1.1. Lamotrigine
- 7.1.1.2.1.2. Phenytoin
- 7.1.1.2.1.3. Carbamazepine
- 7.1.1.2.1.4. Valproic Acid
- 7.1.1.2.1.5. Others
- 7.1.1.2.2. Surgery Treatment
- 7.1.1.2.3. Other Treatments
- 7.1.1.3. Devices
- 7.1.1.3.1. Monitoring Devices
- 7.1.1.3.1.1. Electrocorticography (ECoG) Electrodes
- 7.1.1.3.1.2. Intraoperative Patient Monitoring Devices
- 7.1.1.3.2. Neurostimulation Devices
- 7.1.1.3.2.1. Responsive Neurostimulation
- 7.1.1.3.2.2. Deep Brain Stimulation
- 7.1.1.3.2.3. Vagus Nerve Stimulation
- 7.2. Latin America Epilepsy Treatment Market Outlook, by Seizure Type, Value (US$ Bn), 2018 – 2031
- 7.2.1.1. Generalized Seizures
- 7.2.1.2. Focal Seizures
- 7.2.1.3. Both
- 7.3. Latin America Epilepsy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 7.3.1. Key Highlights
- 7.3.1.1. Hospital Pharmacies
- 7.3.1.2. Retail Pharmacies
- 7.3.1.3. Drug Stores
- 7.3.1.4. Online Pharmacies
- 7.4. Latin America Epilepsy Treatment Market Outlook, by Service Provider, Value (US$ Bn), 2018 – 2031
- 7.4.1. Key Highlights
- 7.4.1.1. Hospitals
- 7.4.1.2. Ambulatory Surgical Centers
- 7.4.1.3. Diagnostic Centers
- 7.4.1.4. Specialty Clinics
- 7.5. Latin America Epilepsy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 7.5.1. Key Highlights
- 7.5.1.1. Brazil Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.2. Brazil Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.3. Brazil Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 7.5.1.4. Brazil Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 7.5.1.5. Mexico Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.6. Mexico Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.7. Mexico Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 7.5.1.8. Mexico Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 7.5.1.9. Argentina Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.10. Argentina Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.11. Argentina Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 7.5.1.12. Argentina Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 7.5.1.13. Rest of Latin America Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.14. Rest of Latin America Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.15. Rest of Latin America Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 7.5.1.16. Rest of Latin America Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis
- 8. Middle East & Africa Epilepsy Treatment Market Outlook, 2018 – 2031
- 8.1. Middle East & Africa Epilepsy Treatment Market Outlook, by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 8.1.1. Key Highlights
- 8.1.1.1. Diagnosis
- 8.1.1.1.1. Inpatient
- 8.1.1.1.2. Outpatient
- 8.1.1.2. Treatment Type
- 8.1.1.2.1. Drugs
- 8.1.1.2.1.1. Lamotrigine
- 8.1.1.2.1.2. Phenytoin
- 8.1.1.2.1.3. Carbamazepine
- 8.1.1.2.1.4. Valproic Acid
- 8.1.1.2.1.5. Others
- 8.1.1.2.2. Surgery Treatment
- 8.1.1.2.3. Other Treatments
- 8.1.1.3. Devices
- 8.1.1.3.1. Monitoring Devices
- 8.1.1.3.1.1. Electrocorticography (ECoG) Electrodes
- 8.1.1.3.1.2. Intraoperative Patient Monitoring Devices
- 8.1.1.3.2. Neurostimulation Devices
- 8.1.1.3.2.1. Responsive Neurostimulation
- 8.1.1.3.2.2. Deep Brain Stimulation
- 8.1.1.3.2.3. Vagus Nerve Stimulation
- 8.2. Middle East & Africa Epilepsy Treatment Market Outlook, by Seizure Type, Value (US$ Bn), 2018 – 2031
- 8.2.1. Key Highlights
- 8.2.1.1. Generalized Seizures
- 8.2.1.2. Focal Seizures
- 8.2.1.3. Both
- 8.3. Middle East & Africa Epilepsy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 8.3.1. Key Highlights
- 8.3.1.1. Hospital Pharmacies
- 8.3.1.2. Retail Pharmacies
- 8.3.1.3. Drug Stores
- 8.3.1.4. Online Pharmacies
- 8.4. Middle East & Africa Epilepsy Treatment Market Outlook, by Service Provider, Value (US$ Bn), 2018 – 2031
- 8.4.1. Key Highlights
- 8.4.1.1. Hospitals
- 8.4.1.2. Ambulatory Surgical Centers
- 8.4.1.3. Diagnostic Centers
- 8.4.1.4. Specialty Clinics
- 8.5. Middle East & Africa Epilepsy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 8.5.1. Key Highlights
- 8.5.1.1. GCC Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.2. GCC Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.3. GCC Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 8.5.1.4. GCC Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 8.5.1.5. South Africa Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.6. South Africa Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.7. South Africa Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 8.5.1.8. South Africa Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 8.5.1.9. Egypt Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.10. Egypt Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.11. Egypt Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 8.5.1.12. Egypt Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 8.5.1.13. Nigeria Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.14. Nigeria Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.15. Nigeria Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 8.5.1.16. Nigeria Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 8.5.1.17. Rest of Middle East & Africa Epilepsy Treatment Market by Diagnosis & Treatment Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.18. Rest of Middle East & Africa Epilepsy Treatment Market by Seizure Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.19. Rest of Middle East & Africa Epilepsy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 – 2031
- 8.5.1.20. Rest of Middle East & Africa Epilepsy Treatment Market by Service Provider, Value (US$ Bn), 2018 – 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis
- 9. Competitive Landscape
- 9.1. Artery Type vs Indication Heatmap
- 9.2. Manufacturer vs Indication Heatmap
- 9.3. Company Market Share Analysis, 2023
- 9.4. Competitive Dashboard
- 9.5. Company Profiles
- 9.5.1. Medtronic PLC
- 9.5.1.1. Company Overview
- 9.5.1.2. Product Portfolio
- 9.5.1.3. Financial Overview
- 9.5.1.4. Business Strategies and Development
- 9.5.2. GlaxoSmithKline PLC
- 9.5.2.1. Company Overview
- 9.5.2.2. Product Portfolio
- 9.5.2.3. Financial Overview
- 9.5.2.4. Business Strategies and Development
- 9.5.3. Sun Pharmaceutical Industries Ltd.
- 9.5.3.1. Company Overview
- 9.5.3.2. Product Portfolio
- 9.5.3.3. Financial Overview
- 9.5.3.4. Business Strategies and Development
- 9.5.4. Novartis AG
- 9.5.4.1. Company Overview
- 9.5.4.2. Product Portfolio
- 9.5.4.3. Financial Overview
- 9.5.4.4. Business Strategies and Development
- 9.5.5. Teva Pharmaceutical Industries Ltd.
- 9.5.5.1. Company Overview
- 9.5.5.2. Product Portfolio
- 9.5.5.3. Financial Overview
- 9.5.5.4. Business Strategies and Development
- 9.5.6. Zydus Cadila Healthcare Ltd.
- 9.5.6.1. Company Overview
- 9.5.6.2. Product Portfolio
- 9.5.6.3. Financial Overview
- 9.5.6.4. Business Strategies and Development
- 9.5.7. Boston Scientific Corporation
- 9.5.7.1. Company Overview
- 9.5.7.2. Product Portfolio
- 9.5.7.3. Financial Overview
- 9.5.7.4. Business Strategies and Development
- 9.5.8. ElectroCore, Inc.
- 9.5.8.1. Company Overview
- 9.5.8.2. Product Portfolio
- 9.5.8.3. Financial Overview
- 9.5.8.4. Business Strategies and Development
- 9.5.9. LivaNova PLC
- 9.5.9.1. Company Overview
- 9.5.9.2. Product Portfolio
- 9.5.9.3. Financial Overview
- 9.5.9.4. Business Strategies and Development
- 9.5.10. Nihon Kohden Corporation
- 9.5.10.1. Company Overview
- 9.5.10.2. Product Portfolio
- 9.5.10.3. Financial Overview
- 9.5.10.4. Business Strategies and Development
- 9.5.11. Natus Medical Incorporated
- 9.5.11.1. Company Overview
- 9.5.11.2. Product Portfolio
- 9.5.11.3. Financial Overview
- 9.5.11.4. Business Strategies and Development
- 9.5.12. Neurosoft, Inc.
- 9.5.12.1. Company Overview
- 9.5.12.2. Product Portfolio
- 9.5.12.3. Financial Overview
- 9.5.12.4. Business Strategies and Development
- 9.5.13. Pfizer, Inc.
- 9.5.13.1. Company Overview
- 9.5.13.2. Product Portfolio
- 9.5.13.3. Financial Overview
- 9.5.13.4. Business Strategies and Development
- 10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook